Choroid In Coronary Artery Disease
Launched by BURSA YÜKSEK İHTISAS EDUCATION AND RESEARCH HOSPITAL · Jun 2, 2024
Trial Information
Current as of February 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Normal coronaries at coronary angiography for healthy control group
- • Without any coronary artery disease equivalent diseases such as peripheral artery disease, cerebrovascular disease and stroke for healthy control group
- • Ability to give informed consent for the study
- • Coronary artery disease with stenosis detected in coronary angiogram for coronary artery disease group
- Exclusion Criteria:
- • High myopia (\> 6D)
- • Cataracts
- • Retinal vascular disease
- • Retinal surgery
- • Retinal dystrophy
- • Laser photocoagulation
- • Intravitreal anti-VEGF treatment
- • Glaucoma
- • Uveitis
- • Retinal disorders (comprising diabetic macular edema, diabetic/hypertensive retinopathy, vein occlusions, retinal dystrophy, epiretinal membrane, vitreomacular traction, age-related macular degeneration)
- • Any systemic diseases
- • Obesity (body-mass index ≥30 kg/m²)
Trial Officials
Hakan Tenekecioglu, MD
Study Director
Balikesir City Hospital
Iskender Kadife, MD
Principal Investigator
Balikesir City Hospital
Erhan Tenekecioglu
Principal Investigator
Saglik Bilimleri Universitesi
About Bursa Yüksek İhtisas Education And Research Hospital
Bursa Yüksek İhtisas Education and Research Hospital is a leading medical institution in Turkey, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on education, the hospital provides cutting-edge training for healthcare professionals while fostering a collaborative environment for scientific inquiry. Its commitment to patient-centered care and rigorous research standards positions it as a key player in the development of new therapies and medical advancements. By actively engaging in clinical trials, Bursa Yüksek İhtisas aims to contribute to the global healthcare landscape and improve treatment outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Balıkesir, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0